Controversies Surrounding the Use of β-Blockers in Older Patients with Cardiovascular Disease
- 6 Downloads
KeywordsCongestive Heart Failure Acute Myocardial Infarction Diastolic Dysfunction Blocker Therapy Xamoterol
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Unable to display preview. Download preview PDF.
- Ferguson DW. Sympathetic mechanisms in heart failure; pathophysiological and pharmacological implications. Circulation 87(Suppl. VII): 68–75, 1993Google Scholar
- Francis GS, Benedict C, Johnstone DE, for the SOLVD Investigators. Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure. A substudy of the studies of left ventricular dysfunction. Circulation 82: 1724–1729, 1990PubMedCrossRefGoogle Scholar
- Hjalmarson A, Herlitz J, Holmberg S, et al. The Göteborg Metoprolol Trial. Effects on mortality and morbidity in acute myocardial infarction. Circulation 67(Suppl. I): 26–32, 1983Google Scholar
- ISIS-1 Collaborative Group. Randomized trial of intravenous atenolol among 16027 cases of suspected acute myocardial infarction. Lancet 2: 57–65, 1986Google Scholar
- MIAMI Trial Research Group. Metoprolol in acute myocardial infarction (MIAMI). A randomized placebo-controlled international trial. European Heart Journal 6: 199–226, 1985Google Scholar
- Packer M, Hung Lee W, Kessler PD, et al. Role of neurohormonal mechanisms in determining survival in patients with severe chronic heart failure. Circulation 75(Suppl. IV): 80–92, 1987Google Scholar
- Yusuf S, Sleight P, Held P, et al. Routine medical management of acute myocardial infarction. Lessons from overviews of recent randomized controlled trials. Circulation 82(Suppl. II): 117–134, 1990Google Scholar
© Adis International Limited 1994